Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. - Wikidata - awgldk - TriplyDB

Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

http://www.wikidata.org/entity/Q36439622

about

Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy Nomograms in oncology: more than meets the eye Cancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancer Emerging critical role of molecular testing in diagnostic genitourinary pathology Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patients A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapy Design of a Global Medical Database which is Searchable by Human Diagnostic Patterns Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy Reporting methods in studies developing prognostic models in cancer: a review.Modeling potential time to event data with competing risks.How to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modeling.The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases Reporting performance of prognostic models in cancer: a review.Postoperative systems models more accurately predict risk of significant disease progression than standard risk groups and a 10-year postoperative nomogram: potential impact on the receipt of adjuvant therapy after surgery.Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases.Derivation of cancer diagnostic and prognostic signatures from gene expression data.Predicting 15-year prostate cancer specific mortality after radical prostatectomy.Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer.The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point.Development of a real-time clinical decision support system upon the Web MVC-based architecture for prostate cancer treatment Prostate cancer postoperative nomogram scores and obesity.Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer.Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.Prediction models in urology: are they any good, and how would we know anyway?Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature.Copy number alteration burden predicts prostate cancer relapse High-throughput detection of prostate cancer in histological sections using probabilistic pairwise Markov models.Critical review of prostate cancer predictive tools Dual inhibition of EGFR and mTOR pathways in small cell lung cancer.What happens after an elevated PSA test: the experience of 13,591 veterans.Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience.Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.Evaluation of prediction models for the staging of prostate cancer.Use of nomograms for predictions of outcome in patients with advanced bladder cancer.Selecting patients for randomized trials: a systematic approach based on risk group.A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy Improving prediction of prostate cancer recurrence using chemical imaging.Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis.

P2860

Q24652928-BD869283-B194-4E7A-AB69-D2E1AE5A4604 Q26830260-8FBDF5BA-CB17-4746-AEB5-6872F3955C35 Q26852766-E03377AD-B9CF-4DA2-9F3A-E457494BF758 Q27021371-64A4B64A-2EDD-4F4E-B0AC-B4AB38ABAA47 Q28539180-D4612614-160A-4352-AD86-254F5A4FEF9D Q28543958-0B3D211C-E8E8-425C-8893-01537CCB4B81 Q28754787-B235A972-A76E-4D95-8CA3-FC5D88E6279F Q30371634-BC602B6E-1F6A-4E13-AD7D-FD2BE5ECA0B6 Q30494142-694C7E2D-EA73-4996-A080-5CEDB31416EB Q30669557-D926502B-68F5-497C-89CB-D666DA657694 Q31159691-BDA7E2EB-D90E-41EA-9C7E-9177E05F0348 Q33516060-3515254A-923A-4E5F-BA38-977CA47CAFB7 Q33547696-4B6C130E-D09E-4937-9242-0815DEF2108F Q33669456-64DA90C3-AEB1-4E5A-A06D-A8591054F4BF Q33705993-EEE6CBDD-11A5-4D62-B0BF-BA8B2843044A Q33748879-D7267795-4779-49CB-90BD-28FBF65538DF Q33759725-BCD1553E-8A33-4555-8C4F-0F573D5DA212 Q33772524-65317319-F551-4B1C-B902-D5F26EF32004 Q33787023-28A6EF48-FB25-41B0-85A1-5B5A034F60CC Q33817319-CEFE345B-B4EF-420E-9A9F-B50D8DCEF37C Q33840337-77B0116A-82A7-4682-BFB5-4BB59C9FA915 Q33841995-17C48819-39C2-4E5B-B3F3-82132D5A761C Q33881033-5E91256D-C7DE-4717-8F61-3D3F77A0D2E6 Q33898869-B120E5FC-F059-407F-BEE1-F02BD285B462 Q33940100-D0045E83-E09C-4884-9D20-C80697C22466 Q33990394-F75E5E40-94DC-48E2-9BB3-D6041824802D Q33993472-0196E368-5D72-496E-ADF9-86C9DB871A6E Q34002312-5AD88EF5-8F33-4497-AE24-BAEBAC091BD4 Q34047679-8618F20F-D64B-43F1-B5AB-C6CB6D466379 Q34104562-E7004E2D-7FA2-4152-BB4A-B27691027DD3 Q34122718-92A26BE8-CF1D-4D77-9279-11A57F6F884A Q34164258-21592C51-A1DE-428E-87F7-730449BE4992 Q34267902-B0BAAB4D-C7D3-4395-BBFD-A1C60AAC117C Q34962331-FF50283C-B969-4A64-9B46-B7EE010F64B9 Q35044520-FA07A06B-D2B0-4039-AA91-CCD8226C3FCB Q35076360-6BF71F53-2AF4-4062-868B-B13DD30406F8 Q35090732-F81F520A-6C24-46F5-A14C-A0ED4BC1C33A Q35096149-2995207D-1234-421E-8937-A9E87E7BF7EA Q35144197-AF1E7464-7584-4D0F-8C44-C992C0A34F4B Q35167186-8D16E814-9EDC-4332-86B6-294555E3F433

P2860

Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

http://www.wikidata.org/entity/Q36439622

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Postoperative nomogram predict ...... e after radical prostatectomy.

@ast

Postoperative nomogram predict ...... e after radical prostatectomy.

@en

type

label

Postoperative nomogram predict ...... e after radical prostatectomy.

@ast

Postoperative nomogram predict ...... e after radical prostatectomy.

@en

prefLabel

Postoperative nomogram predict ...... e after radical prostatectomy.

@ast

Postoperative nomogram predict ...... e after radical prostatectomy.

@en

P1433

Q36439622-41A43406-3E86-40B2-856E-7885EBD5B404

P1476

Q36439622-C5EDF3E4-046D-4E80-903F-8934893F2C4C

P2093

Q36439622-03583B1B-2D31-4CDD-B5D4-E71BAFD4A000

Q36439622-1E97AD32-9774-42A5-90A7-4CD4218DEE7E

Q36439622-319E5A54-7C2B-415D-BA03-FC5E12FC1F42

Q36439622-56DF7F72-B4BF-4466-97FE-5BF9B21DE82A

Q36439622-A6EE3F3F-0DCE-4619-A065-CED83047A38A

Q36439622-AFB9D986-AA77-44E4-9C47-2AC9892F904E

Q36439622-DBEEF496-10F0-4D63-965E-81220D7E3E82

Q36439622-E4D03880-5F84-400C-BCF7-F77AAEB0B3A7

Q36439622-F75059E3-F8DC-4FD5-A7AB-41A5EF78B3C9

P2860

Q36439622-01698265-9D91-4E17-9FBE-DF0EAF7EFE10

Q36439622-1C86904E-3AAC-47E9-844E-EFF4E4A74106

Q36439622-3AEB7E85-4A9C-4D36-8697-A08D3C30E305

Q36439622-46F40761-DF70-44C8-8964-2B4C280B9C2C

Q36439622-6DDF5884-23D7-495A-82AA-3E0A98953C0D

Q36439622-70213673-ACA1-40EF-92B6-2DEF7EF61133

Q36439622-7C6CB816-0F3F-41D0-990B-D776E769A871

Q36439622-9E9299CD-B0C9-47CD-A877-8B87416A04A7

Q36439622-B220020E-9300-44CA-821E-1638AEB9913D

Q36439622-B7F3F27F-301D-410C-80D5-8DA71DF82A9F

P304

Q36439622-430248BE-DC48-4404-BB45-C2033AECCFD2

P31

Q36439622-3A48FA8D-B3F9-4770-B296-C0501D4EAFEF

P356

Q36439622-B05A797B-C537-4513-B376-2882F0F7FBB3

P407

Q36439622-4F519237-8C1D-4704-98C3-61BD633CBA0D

P433

Q36439622-A65C2F8E-B74E-4CD1-BF91-7E6EB8E1185A

P478

Q36439622-705E55D7-FD95-4953-B2B6-D7D5F9D7CBA2

P577

Q36439622-23328C42-5C0B-4761-9CD3-825DA28E0D28

P698

Q36439622-B5325E3F-8505-49D2-AE8D-1A97A57BC5AC

P932

Q36439622-2DB6C56B-D2F4-42CC-ADA4-D87C58D7517C

P356

JCO.2005.01.867

P1433

Journal of Clinical Oncology

P1476

Postoperative nomogram predict ...... e after radical prostatectomy.

@en

P2093

Alwyn Reuther

http://www.w3.org/2001/XMLSchema#string

Andrew J Stephenson

http://www.w3.org/2001/XMLSchema#string

Christopher J DiBlasio

http://www.w3.org/2001/XMLSchema#string

Eric A Klein

http://www.w3.org/2001/XMLSchema#string

Fernando J Bianco

http://www.w3.org/2001/XMLSchema#string

James A Eastham

http://www.w3.org/2001/XMLSchema#string

Michael W Kattan

http://www.w3.org/2001/XMLSchema#string

Peter T Scardino

http://www.w3.org/2001/XMLSchema#string

Zohar A Dotan

http://www.w3.org/2001/XMLSchema#string

P2860

Natural history of progression after PSA elevation following radical prostatectomy.

Evaluating the yield of medical tests.

Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy.

Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.

Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).

Radical prostatectomy nomograms in black American men: accuracy and applicability.

P304

7005-7012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.01.867

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16192588

http://www.w3.org/2001/XMLSchema#string

P932

2231088

http://www.w3.org/2001/XMLSchema#string